The forkhead transcription factor FOXP2 is required for regulation of p21waf1/cip1 in 143B osteosarcoma cell growth arrest

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Gascoyne, Duncan M ^a   Spearman, Hayley ^a   Lyne, Linden ^a   Puliyadi, Rathi ^b   Perez Alcantara, Marta ^a   Coulton, Les ^c   Fisher, Simon E ^d   Croucher, Peter I ^e   Banham, Alison H ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

^d RADBOUD UNIVERSITY   (Netherlands)

^e GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; TRANSCRIPTION FACTOR FOXP2; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; FORKHEAD TRANSCRIPTION FACTOR; FOXP2 PROTEIN, HUMAN; MESSENGER RNA;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CONTROLLED STUDY; EMBRYO; GROWTH DISORDER; HUMAN; HUMAN CELL; MESENCHYME CELL; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOSARCOMA CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; APOPTOSIS; BONE TUMOR; C57BL MOUSE; CELL CULTURE; CELL CYCLE; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CYTOLOGY; ENZYME IMMUNOASSAY; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; OSTEOSARCOMA; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

MURINAE;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; BONE NEOPLASMS; CELL CYCLE; CELL PROLIFERATION; CELLS, CULTURED; CHROMATIN IMMUNOPRECIPITATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MICE; MICE, INBRED C57BL; OSTEOBLASTS; OSTEOSARCOMA; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 84934908954     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0128513     Document Type: Article

References (51)

1. Shu W, Yang H, Zhang L, Lu MM, Morrisey EE. Characterization of a new subfamily of winged-helix/forkhead (Fox) genes that are expressed in the lung and act as transcriptional repressors. The Journal of biological chemistry. 2001;276(29):27488-97. doi: 10.1074/jbc. M100636200 PMID: 11358962.
2. Lai CS, Fisher SE, Hurst JA, Vargha-Khadem F, Monaco AP. A forkhead-domain gene is mutated in a severe speech and language disorder. Nature. 2001;413(6855):519-23. Epub 2001/10/05. doi:10.1038/3509707635097076 [pii]. PMID: 11586359.
3. Spiteri E, Konopka G, Coppola G, Bomar J, Oldham M, Ou J, et al. Identification of the transcriptional targets of FOXP2, a gene linked to speech and language, in developing human brain. Am J Hum Genet. 2007;81(6):1144-57. Epub 2007/11/14. S0002-9297 (07) 63765-3 [pii] doi: 10.1086/522237 PMID: 17999357; PubMed Central PMCID: PMC2276350.
4. Vernes SC, Spiteri E, Nicod J, Groszer M, Taylor JM, Davies KE, et al. High-throughput analysis of promoter occupancy reveals direct neural targets of FOXP2, a gene mutated in speech and language disorders. Am J Hum Genet. 2007;81(6):1232-50. Epub 2007/11/14. S0002-9297 (07) 63771-9 [pii] doi: 10.1086/522238 PMID: 17999362; PubMed Central PMCID: PMC2276341.
5. Lai CS, Gerrelli D, Monaco AP, Fisher SE, Copp AJ. FOXP2 expression during brain development coincides with adult sites of pathology in a severe speech and language disorder. Brain. 2003;126(Pt 11):2455-62. Epub 2003/07/24. doi: 10.1093/brain/awg247awg247 [pii]. PMID: 12876151.
6. Teramitsu I, Kudo LC, London SE, Geschwind DH, White SA. Parallel FoxP1 and FoxP2 expression in songbird and human brain predicts functional interaction. J Neurosci. 2004;24(13):3152-63. Epub 2004/04/02. doi: 10.1523/JNEUROSCI.5589-03.200424/13/3152 [pii]. PMID: 15056695.
7. Shah R, Medina-Martinez O, Chu LF, Samaco RC, Jamrich M. Expression of FoxP2 during zebrafish development and in the adult brain. Int J Dev Biol. 2006;50(4):435-8. Epub 2006/03/10. 052065rs [pii] doi: 10.1387/ijdb.052065rs PMID: 16525940.
8. Fisher SE, Scharff C. FOXP2 as a molecular window into speech and language. Trends Genet. 2009;25(4):166-77. Epub 2009/03/24. S0168-9525 (09) 00043-2 [pii] doi: 10.1016/j.tig.2009.03.002 PMID: 19304338.
9. Banham AH, Beasley N, Campo E, Fernandez PL, Fidler C, Gatter K, et al. The FOXP1 winged helix transcription factor is a novel candidate tumor suppressor gene on chromosome 3p. Cancer research. 2001;61(24):8820-9. PMID: 11751404.
10. Hu H, Wang B, Borde M, Nardone J, Maika S, Allred L, et al. Foxp1 is an essential transcriptional regulator of B cell development. Nature immunology. 2006;7(8):819-26. doi: 10.1038/ni1358 PMID: 16819554.
11. Campbell AJ, Lyne L, Brown PJ, Launchbury RJ, Bignone P, Chi J, et al. Aberrant expression of the neuronal transcription factor FOXP2 in neoplastic plasma cells. Br J Haematol. 2010;149(2):221-30. Epub 2010/01/26. BJH8070 [pii] doi: 10.1111/j.1365-2141.2009.08070.x PMID: 20096010.
12. Brown PJ, Campbell AJ, Lyne L, Chi J, Lawrie CH, Kusec R, et al. Expression of the FOXP1 transcription factor is post-transcriptionally silenced in normal and malignant CD138+ plasma cells. The Open Leukemia Journal. 2010;3(1):16-23. Epub 2010/01/22. doi: 10.2174/1876816401003010016
13. Leishman E, Howard JM, Garcia GE, Miao Q, Ku AT, Dekker JD, et al. Foxp1 maintains hair follicle stem cell quiescence through regulation of Fgf18. Development. 2013;140(18):3809-18. doi: 10.1242/dev. 097477 PMID: 23946441; PubMed Central PMCID: PMC3754479.
14. Wang B, Weidenfeld J, Lu MM, Maika S, Kuziel WA, Morrisey EE, et al. Foxp1 regulates cardiac outflow tract, endocardial cushion morphogenesis and myocyte proliferation and maturation. Development. 2004;131(18):4477-87. doi: 10.1242/dev. 01287 PMID: 15342473.
15. el-Deiry WS, Harper JW, O'Connor PM, Velculescu VE, Canman CE, Jackman J, et al. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res. 1994;54(5):1169-74. Epub 1994/03/01. PMID: 8118801.
16. Groszer M, Keays DA, Deacon RM, de Bono JP, Prasad-Mulcare S, Gaub S, et al. Impaired synaptic plasticity and motor learning in mice with a point mutation implicated in human speech deficits. Curr Biol. 2008;18(5):354-62. Epub 2008/03/11. S0960-9822 (08) 00157-7 [pii] doi: 10.1016/j.cub.2008.01. 060 PMID: 18328704; PubMed Central PMCID: PMC2917768.
17. Enard W, Gehre S, Hammerschmidt K, Holter SM, Blass T, Somel M, et al. A humanized version of Foxp2 affects cortico-basal ganglia circuits in mice. Cell. 2009;137(5):961-71. Epub 2009/06/06. S0092-8674 (09) 00378-X [pii] doi: 10.1016/j.cell.2009.03.041 PMID: 19490899.
18. Konopka G, Bomar JM, Winden K, Coppola G, Jonsson ZO, Gao F, et al. Human-specific transcriptional regulation of CNS development genes by FOXP2. Nature. 2009;462(7270):213-7. Epub 2009/11/13. nature08549 [pii] 10.1038/nature08549.19907493; PubMed Central PMCID: PMC2778075. doi: 10. 1038/nature08549 PMID: 19907493
19. Vernes SC, Oliver PL, Spiteri E, Lockstone HE, Puliyadi R, Taylor JM, et al. Foxp2 regulates gene networks implicated in neurite outgrowth in the developing brain. PLoS Genet. 2011;7(7):e1002145. Epub 2011/07/19. doi: 10.1371/journal.pgen. 1002145PGENETICS-D-10-00151 [pii]. PMID: 21765815; PubMed Central PMCID: PMC3131290.
20. Rousso DL, Pearson CA, Gaber ZB, Miquelajauregui A, Li S, Portera-Cailliau C, et al. Foxp-mediated suppression of N-cadherin regulates neuroepithelial character and progenitor maintenance in the CNS. Neuron. 2012;74(2):314-30. Epub 2012/05/01. S0896-6273 (12) 00232-2 [pii] doi: 10.1016/j.neuron. 2012.02.024 PMID: 22542185; PubMed Central PMCID: PMC3444171.
21. Shu W, Cho JY, Jiang Y, Zhang M, Weisz D, Elder GA, et al. Altered ultrasonic vocalization in mice with a disruption in the Foxp2 gene. Proc Natl Acad Sci U S A. 2005;102(27):9643-8. Epub 2005/06/29. 0503739102 [pii] doi: 10.1073/pnas.0503739102 PMID: 15983371; PubMed Central PMCID: PMC1160518.
22. Haesler S, Rochefort C, Georgi B, Licznerski P, Osten P, Scharff C. Incomplete and inaccurate vocal imitation after knockdown of FoxP2 in songbird basal ganglia nucleus Area X. PLoS Biol. 2007;5(12):e321. Epub 2007/12/07. 06-PLBI-RA-1785 [pii] doi: 10.1371/journal.pbio.0050321 PMID: 18052609; PubMed Central PMCID: PMC2100148.
23. Shu W, Lu MM, Zhang Y, Tucker PW, Zhou D, Morrisey EE. Foxp2 and Foxp1 cooperatively regulate lung and esophagus development. Development. 2007;134(10):1991-2000. Epub 2007/04/13. dev. 02846 [pii] doi: 10.1242/dev. 02846 PMID: 17428829.
24. Kurt S, Groszer M, Fisher SE, Ehret G. Modified sound-evoked brainstem potentials in Foxp2 mutant mice. Brain Res. 2009;1289:30-6. Epub 2009/07/15. S0006-8993 (09) 01366-3 [pii] doi: 10.1016/j. brainres.2009.06.092 PMID: 19596273.
25. French CA, Jin X, Campbell TG, Gerfen E, Groszer M, Fisher SE, et al. An aetiological Foxp2 mutation causes aberrant striatal activity and alters plasticity during skill learning. Mol Psychiatry. 2012;17(11):1077-85. Epub 2011/08/31. mp2011105 [pii] doi: 10.1038/mp. 2011.105 PMID: 21876543; PubMed Central PMCID: PMC3481071.
26. Kurt S, Fisher SE, Ehret G. Foxp2 mutations impair auditory-motor association learning. PLoS One. 2012;7(3):e33130. Epub 2012/03/14. doi: 10.1371/journal.pone. 0033130PONE-D-11-13519 [pii]. PMID: 22412993; PubMed Central PMCID: PMC3296769.
27. Shi C, Sakuma M, Mooroka T, Liscoe A, Gao H, Croce KJ, et al. Down-regulation of the forkhead transcription factor Foxp1 is required for monocyte differentiation and macrophage function. Blood. 2008;112(12):4699-711. doi: 10.1182/blood-2008-01-137018 PMID: 18799727; PubMed Central PMCID: PMC2597137.
28. Bonewald LF, Schwartz Z, Swain LD, Boyan BD. Stimulation of matrix vesicle enzyme activity in osteoblastlike cells by 1, 25 (OH) 2D3 and transforming growth factor beta (TGF beta). Bone Miner. 1992;17(2):139-44. Epub 1992/05/01. PMID: 1611299.
29. Fowler JA, Edwards CM, Croucher PI. Tumor-host cell interactions in the bone disease of myeloma. Bone. 2011;48(1):121-8. Epub 2010/07/10. S8756-3282 (10) 01343-8 [pii] doi: 10.1016/j.bone.2010. 06.029 PMID: 20615487; PubMed Central PMCID: PMC3005983.
30. Colla S, Morandi F, Lazzaretti M, Rizzato R, Lunghi P, Bonomini S, et al. Human myeloma cells express the bone regulating gene Runx2/Cbfa1 and produce osteopontin that is involved in angiogenesis in multiple myeloma patients. Leukemia. 2005;19(12):2166-76. Epub 2005/10/07. 2403976 [pii] doi: 10. 1038/sj.leu.2403976 PMID: 16208410.
31. Zhao H, Zhou W, Yao Z, Wan Y, Cao J, Zhang L, et al. Foxp1/2/4 regulate endochondral ossification as a suppresser complex. Developmental biology. 2014. doi: 10.1016/j.ydbio.2014.12.007 PMID: 25527076.
32. Thomas DM, Johnson SA, Sims NA, Trivett MK, Slavin JL, Rubin BP, et al. Terminal osteoblast differentiation, mediated by runx2 and p27KIP1, is disrupted in osteosarcoma. J Cell Biol. 2004;167(5):925-34. Epub 2004/12/08. jcb.200409187 [pii] doi: 10.1083/jcb.200409187 PMID: 15583032; PubMed Central PMCID: PMC2172443.
33. Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 1999;13(12):1501-12. Epub 1999/07/01. PMID: 10385618.
34. Toogood PL, Harvey PJ, Repine JT, Sheehan DJ, VanderWel SN, Zhou H, et al. Discovery of a potent and selective inhibitor of cyclin-dependent kinase 4/6. J Med Chem. 2005;48(7):2388-406. Epub 2005/04/02. doi: 10.1021/jm049354h PMID: 15801831.
35. Bellido T, O'Brien CA, Roberson PK, Manolagas SC. Transcriptional activation of the p21 (WAF1, CIP1, SDI1) gene by interleukin-6 type cytokines. A prerequisite for their pro-differentiating and anti-apoptotic effects on human osteoblastic cells. The Journal of biological chemistry. 1998;273(33):21137-44. Epub 1998/08/08. PMID: 9694869.
36. Kawashima H, Takatori H, Suzuki K, Iwata A, Yokota M, Suto A, et al. Tumor suppressor p53 inhibits systemic autoimmune diseases by inducing regulatory T cells. J Immunol. 2013;191(7):3614-23. Epub 2013/09/06. jimmunol.1300509 [pii] doi: 10.4049/jimmunol.1300509 PMID: 24006461.
37. Rao DS, O'Connell RM, Chaudhuri AA, Garcia-Flores Y, Geiger TL, Baltimore D. MicroRNA-34a perturbs B lymphocyte development by repressing the forkhead box transcription factor Foxp1. Immunity. 2010;33(1):48-59. doi: 10.1016/j.immuni.2010.06.013 PMID: 20598588; PubMed Central PMCID: PMC2911227.
38. Romano JW, Ehrhart JC, Duthu A, Kim CM, Appella E, May P. Identification and characterization of a p53 gene mutation in a human osteosarcoma cell line. Oncogene. 1989;4(12):1483-8. Epub 1989/12/01. PMID: 2531855.
39. Ridgway PJ, Hall AR, Myers CJ, Braithwaite AW. p53/E1b58kDa complex regulates adenovirus replication. Virology. 1997;237(2):404-13. Epub 1997/11/14. S0042-6822 (97) 98782-1 [pii] doi: 10.1006/viro.1997.8782 PMID: 9356351.
40. Long F. Building strong bones: molecular regulation of the osteoblast lineage. Nat Rev Mol Cell Biol. 2012;13(1):27-38. Epub 2011/12/23. nrm3254 [pii] doi: 10.1038/nrm3254 PMID: 22189423.
41. Bi W, Deng JM, Zhang Z, Behringer RR, de Crombrugghe B. Sox9 is required for cartilage formation. Nature genetics. 1999;22(1):85-9. doi: 10.1038/8792 PMID: 10319868.
42. Zhao Y, Guo YJ, Tomac AC, Taylor NR, Grinberg A, Lee EJ, et al. Isolated cleft palate in mice with a targeted mutation of the LIM homeobox gene lhx8. Proc Natl Acad Sci U S A. 1999;96(26):15002-6. Epub 1999/12/28. PMID: 10611327; PubMed Central PMCID: PMC24762.
43. Denaxa M, Sharpe PT, Pachnis V. The LIM homeodomain transcription factors Lhx6 and Lhx7 are key regulators of mammalian dentition. Developmental biology. 2009;333(2):324-36. Epub 2009/07/14. S0012-1606 (09) 01033-1 [pii] doi: 10.1016/j.ydbio.2009.07.001 PMID: 19591819; PubMed Central PMCID: PMC2738952.
44. Bellosta P, Masramon L, Mansukhani A, Basilico C. p21 (WAF1/CIP1) acts as a brake in osteoblast differentiation. J Bone Miner Res. 2003;18(5):818-26. Epub 2003/05/08. doi: 10.1359/jbmr.2003.18.5. 818 PMID: 12733720.
45. Franchimont N, Wertz S, Malaise M. Interleukin-6: An osteotropic factor influencing bone formation? Bone. 2005;37(5):601-6. Epub 2005/08/23. S8756-3282 (05) 00251-6 [pii] doi: 10.1016/j.bone.2005. 06.002 PMID: 16112634.
46. Di Giorgio E, Gagliostro E, Clocchiatti A, Brancolini C. The Control Operated by the Cell Cycle Machinery on MEF2 Stability Contributes to the Downregulation of CDKN1A and Entry into S Phase. Molecular and cellular biology. 2015;35(9):1633-47. doi: 10.1128/MCB.01461-14 PMID: 25733682.
47. Marques-Torrejon MA, Porlan E, Banito A, Gomez-Ibarlucea E, Lopez-Contreras AJ, Fernandez-Capetillo O, et al. Cyclin-dependent kinase inhibitor p21 controls adult neural stem cell expansion by regulating Sox2 gene expression. Cell Stem Cell. 2013;12(1):88-100. Epub 2012/12/25. S1934-5909 (12) 00705-9 [pii] doi: 10.1016/j.stem.2012.12.001 PMID: 23260487; PubMed Central PMCID: PMC3714747.
48. Hu H, Djuretic I, Sundrud MS, Rao A. Transcriptional partners in regulatory T cells: Foxp3, Runx and NFAT. Trends Immunol. 2007;28(8):329-32. Epub 2007/07/10. S1471-4906 (07) 00160-3 [pii] doi: 10. 1016/j.it.2007.06.006 PMID: 17618833.
49. Wang J, Ioan-Facsinay A, van der Voort EI, Huizinga TW, Toes RE. Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells. Eur J Immunol. 2007;37(1):129-38. Epub 2006/12/13. doi: 10.1002/eji.200636435 PMID: 17154262.
50. Lengner CJ, Steinman HA, Gagnon J, Smith TW, Henderson JE, Kream BE, et al. Osteoblast differentiation and skeletal development are regulated by Mdm2-p53 signaling. J Cell Biol. 2006;172(6):909-21. Epub 2006/03/15. jcb.200508130 [pii] doi: 10.1083/jcb.200508130 PMID: 16533949; PubMed Central PMCID: PMC2063734.
51. Kansara M, Thomas DM. Molecular pathogenesis of osteosarcoma. DNA Cell Biol. 2007;26(1):1-18. Epub 2007/02/01. doi: 10.1089/dna.2006.0505 PMID: 17263592.